跳至主要内容
临床试验/IRCT20210413050957N1
IRCT20210413050957N1招募中3 期

Survey the effect of magnesium citrate supplementation on clinical symptoms and TNF-a and hs-CRP factors in patients with COVID-19

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Laboratory confirmation of Covid-19 (2019-nCoV Real-Time RT-PCR)
  • Patients with moderate status
  • Age from 18 to 65 years
  • gender: male/female

排除标准

  • Hospitalization of the patient in the intensive care unit
  • Underlying diseases such as diabetes, hypertension, cardiovascular disease, kidney disease and mental disorders such as depression
  • Obesity (BMI = 30)
  • Vitamin D level less than 30 ng / ml
  • Hypomagnesemia (magnesium level less than 1.7 mg / dL) and hypermagnesemia (magnesium level higher than 2.6 mg / dL)
  • Pregnancy and lactation
  • Contraindications, intolerance or allergy to magnesium
  • Taking dietary supplements
  • Alcohol and drug abuse

研究者

相似试验